249 related articles for article (PubMed ID: 22997451)
1. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Colombo N; Carinelli S; Colombo A; Marini C; Rollo D; Sessa C;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii27-32. PubMed ID: 22997451
[No Abstract] [Full Text] [Related]
2. Cervical cancer.
Greer BE; Koh WJ; Abu-Rustum N; Bookman MA; Bristow RE; Campos S; Cho KR; Copeland L; Eifel P; Huh WK; Jaggernauth W; Kapp DS; Kavanagh J; Lipscomb GH; Lurain JR; Morgan M; Morgan RJ; Powell CB; Remmenga SW; Reynolds RK; Secord AA; Small W; Teng N;
J Natl Compr Canc Netw; 2008 Jan; 6(1):14-36. PubMed ID: 18267056
[No Abstract] [Full Text] [Related]
3. [Topics in histopathological diagnosis of cancer of the uterine cervix].
Tsuda H
Nihon Rinsho; 2004 Oct; 62 Suppl 10():119-22. PubMed ID: 15535218
[No Abstract] [Full Text] [Related]
4. Practice guidelines: cervical cancer. Society of Gynecologic Oncologists Medical Practice Ethics Committee.
Oncology (Williston Park); 1998 Jan; 12(1):134-8. PubMed ID: 9474593
[No Abstract] [Full Text] [Related]
5. ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas, number 35, May 2002.
Committee on Practice Bulletins-Gynecology
Obstet Gynecol; 2002 May; 99(5 Pt 1):855-67. PubMed ID: 11978302
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Haie-Meder C; Morice P; Castiglione M;
Ann Oncol; 2010 May; 21 Suppl 5():v37-40. PubMed ID: 20555099
[No Abstract] [Full Text] [Related]
7. Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer: long-term results.
Mori T; Hosokawa K; Sawada M; Kuroboshi H; Tatsumi H; Koshiba H; Okubo T; Kitawaki J
Int J Gynecol Cancer; 2010 May; 20(4):611-6. PubMed ID: 20686381
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of uterine artery chemoembolization and internal iliac arterial infusion chemotherapy for the combining treatment for women with locally advanced cervical cancer].
Yu L; Tan GS; Xiang XH; Guo WB; Li HP; Huang YH; Yang JY
Ai Zheng; 2009 Apr; 28(4):402-7. PubMed ID: 19622301
[TBL] [Abstract][Full Text] [Related]
9. NACT and laparoscopic-assisted radical vaginal trachelectomy in young patients with large (2-5 cm) high risk cervical cancers: Safety and obstetrical outcome.
Marchiolè P; Ferraioli D; Moran E; Mammoliti S; Tigaud JD; Beurrier F; Chopin N; Mathevet P
Surg Oncol; 2018 Jun; 27(2):236-244. PubMed ID: 29937177
[No Abstract] [Full Text] [Related]
10. Outcome of patients with incomplete resection after surgery for stage IB2/II cervical carcinoma with chemoradiation therapy.
Uzan C; Vincens E; Balleyguier C; Gouy S; Pautier P; Duvillard P; Haie-Meder C; Morice P
Int J Gynecol Cancer; 2010 Apr; 20(3):379-84. PubMed ID: 20375801
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of 4223 hospitalized patients with cervical cancer during 1990-2007].
Wu YY; Liang MR; Li LY; Zeng SY
Zhonghua Fu Chan Ke Za Zhi; 2008 Jun; 43(6):433-6. PubMed ID: 19035138
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.
Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS
Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809
[TBL] [Abstract][Full Text] [Related]
13. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of the head and neck.
Pivot X;
Ann Oncol; 2003 Jul; 14(7):1014-5. PubMed ID: 12853341
[No Abstract] [Full Text] [Related]
14. Comparison of clinical efficacy of three different neoadjuvant approaches (chemotherapy combined vaginal intracavitary irradiation, neoadjuvant chemotherapy alone or radiotherapy) combined with surgery for patients with stage Ib2 and IIa2 cervical cancer.
Fu JH; Gao Z; Ren CC; Shi YG
Asian Pac J Cancer Prev; 2013; 14(4):2377-81. PubMed ID: 23725144
[TBL] [Abstract][Full Text] [Related]
15. [Individualization of treatment based on biological behavior in uterine cervical cancer].
Teshima K; Yamamoto K; Noda K
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2726-33. PubMed ID: 3753021
[TBL] [Abstract][Full Text] [Related]
16. [Adenocarcinoma of the uterine cervix].
Inoue Y; Noda K
Gan No Rinsho; 1989 Oct; 35(13):1610-4. PubMed ID: 2685397
[TBL] [Abstract][Full Text] [Related]
17. Glassy cell carcinoma of the uterine cervix: combination chemotherapy with paclitaxel and carboplatin in recurrent tumor.
Matsuura Y; Murakami N; Nagashio E; Toki N; Kashimura M
J Obstet Gynaecol Res; 2001 Jun; 27(3):129-32. PubMed ID: 11561828
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of the cervix stage IA. Diagnosis and treatment.
Kolstad P
Am J Obstet Gynecol; 1969 Aug; 104(7):1015-22. PubMed ID: 5794830
[No Abstract] [Full Text] [Related]
19. Investigation of uterine arterial chemoembolization and uterine arterial infusion chemotherapy for advanced cervical cancer before radical radiotherapy: a long-term follow-up study.
Tian ZZ; Li S; Wang Y; Yue YJ; Zhu XH; Zhao R; Zhang CL; Wei SH
Arch Gynecol Obstet; 2014 Jul; 290(1):155-62. PubMed ID: 24573504
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Parameters for Patients with Cervical Cancer FIGO Stages IA2-IIB: A Long-Term Follow-Up.
Obrzut B; Semczuk A; Naróg M; Obrzut M; Król P
Oncology; 2017; 93(2):106-114. PubMed ID: 28463843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
